Skip to content

Initial Appointment Education
Annual Mandatory Regulatory Education 2024
Re-Appointment Education
EMR / General Education Materials
Resources
- HIM Resources
- Corporate Compliance Resources
Residents/Fellows

Search Search Close

Search for:

Home
Quiz
Quizzes & Surveys
july2023tranexamicacidfornoac-relatedich

july2023tranexamicacidfornoac-relatedich

Welcome to your july2023tranexamicacidfornoac-relatedich

Tranexamic acid was found to be effective in preventing hematoma expansion in patients with ICH who were taking NOACs.

True

False

None

Which of the following is a limitation of the TICH-NOAC study?

The study was limited by its small sample size.

The study was limited by its short follow-up period.

The study did not include patients with severe ICH.

All of the above

None

The TICH-2 trial found that tranexamic acid was unsafe to use in patients with ICH and did not reduce the rate of hematoma expansion in patients with ICH.

True

False

None

Time's up

Post navigation

Previous Previous post: April 2023: Ischemic Stroke (1.0 Stroke Education Credit)

Next Next post: January Neuroscience Grand Rounds

Education Soul by WEN Themes